Can You Use Mounjaro in Singapore If You Have PCOS or Insulin Resistance?
You may be able to use Mounjaro in Singapore if you have PCOS, but PCOS or insulin resistance alone does not automatically make it suitable. Mounjaro is listed in Singapore as a Prescription Only Medicine, with indications for adults with insufficiently controlled type 2 diabetes and for weight management in adults who meet BMI and comorbidity criteria. For broader eligibility and overview context, see How Singapore Doctors Determine Suitability for Mounjaro Medication and What You Need to Know About Mounjaro Medications in Singapore.
Key Takeaways
PCOS is not itself listed as a standalone Mounjaro indication in Singapore product information.
A doctor may assess Mounjaro if PCOS overlaps with BMI eligibility, type 2 diabetes, prediabetes, dyslipidaemia, hypertension, or other metabolic risks.
PCOS is commonly linked with insulin resistance and increased risk of impaired glucose tolerance and type 2 diabetes.
International PCOS guidance says anti-obesity medications, including GLP-1 receptor agonists, could be considered for higher weight in adults with PCOS as per general population guidelines, alongside lifestyle intervention.
Pregnancy plans, contraception, menstrual history, glucose results, and current medicines should be discussed before treatment.
Why PCOS and Insulin Resistance Come Up in Mounjaro Consultations
PCOS is a reproductive and metabolic condition. SingHealth describes PCOS as a common endocrine disorder in reproductive-age women, associated with chronic anovulation, hyperandrogenism, and polycystic ovaries.
Many people with PCOS also experience weight gain, insulin resistance, impaired glucose tolerance, or type 2 diabetes risk. SingHealth notes that adolescents and adult women with PCOS are at increased risk for impaired glucose tolerance and type 2 diabetes.
This is why PCOS may be relevant during a Mounjaro consultation. The doctor is usually not assessing PCOS alone, but the wider metabolic picture.
Is Mounjaro Approved Specifically for PCOS?
Singapore product information does not list PCOS as a standalone indication for Mounjaro.
Instead, it lists Mounjaro for adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise, and for weight management in adults who meet BMI-based criteria.
This distinction matters. A person with PCOS may be considered if they meet approved clinical criteria, but Mounjaro should not be framed as a direct PCOS treatment or fertility treatment.
When PCOS May Support a Suitability Discussion
PCOS may support the clinical discussion when it occurs together with weight-related or metabolic risk.
For weight management, Singapore product information states that Mounjaro is indicated as an adjunct to reduced-calorie diet and increased physical activity in adults with BMI ≥30 kg/m², or BMI ≥27 kg/m² to <30 kg/m² with at least one weight-related comorbid condition. Listed examples include hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes.
PCOS itself is not named in that list. However, PCOS may coexist with conditions that are listed, such as prediabetes, type 2 diabetes, high cholesterol, or high blood pressure.
What About Insulin Resistance Without Diabetes?
Insulin resistance is a common concept in PCOS care, but it is not always measured directly in routine practice.
The 2023 International Evidence-Based Guideline for PCOS states that insulin resistance is a pathophysiological factor in PCOS, but clinically available insulin assays are of limited clinical relevance and are not recommended in routine care.
For this reason, doctors may focus more on practical metabolic markers such as HbA1c, fasting glucose, oral glucose tolerance testing, lipid profile, blood pressure, BMI, waist-related risk, and medical history.
What Doctors May Check Before Prescribing
A Singapore doctor may review whether the patient’s PCOS is associated with broader metabolic risk.
This may include:
current weight, height, and BMI
menstrual history and PCOS diagnosis details
signs of hyperandrogenism, such as acne or excess hair growth
HbA1c, fasting glucose, or oral glucose tolerance test results
cholesterol and triglyceride levels
blood pressure
current medicines, including metformin or hormonal contraception
pregnancy plans or fertility treatment
kidney, liver, gallbladder, and gastrointestinal history
previous weight-management attempts
This helps the doctor decide whether Mounjaro is suitable, whether another treatment should be prioritised, or whether further testing is needed first.
How PCOS Guidelines View Weight-Management Medicines
International PCOS guidance recognises that weight management can be relevant for adults with PCOS and higher weight.
The 2023 guideline states that anti-obesity medications, including GLP-1 receptor agonists, could be considered in addition to active lifestyle intervention for management of higher weight in adults with PCOS, following general population guidelines. It also recommends gradual dose escalation for GLP-1 receptor agonists to reduce gastrointestinal adverse effects.
This does not mean every person with PCOS should use Mounjaro. It supports a doctor-led, criteria-based discussion when higher weight and metabolic risk are present.
Pregnancy and Fertility Plans Are Important
PCOS is often discussed in the context of fertility, irregular cycles, or ovulation.
If pregnancy is possible or being planned, this should be discussed before starting any prescription weight-management medicine. The 2023 PCOS guideline says healthcare professionals should ensure effective contraception when pregnancy is possible for women taking GLP-1 receptor agonists, because pregnancy safety data are lacking.
Mounjaro should not be used as a fertility medicine. If fertility treatment is planned, the prescribing doctor may coordinate with a gynaecologist or fertility specialist.
What If You Are Already Taking Metformin?
Many people with PCOS or insulin resistance are prescribed metformin, especially when metabolic risk is present.
Singapore product information states that when tirzepatide is added to existing metformin therapy, the current metformin dose can be continued.
However, patients should not combine medicines on their own. A doctor should review gastrointestinal side effects, glucose results, kidney function, treatment goals, and whether metformin remains appropriate.
What If You Have Prediabetes or Type 2 Diabetes?
Prediabetes or type 2 diabetes changes the assessment.
Singapore product information includes prediabetes and type 2 diabetes mellitus among examples of weight-related comorbid conditions for adults with BMI ≥27 kg/m² to <30 kg/m² under the weight-management indication. It also lists Mounjaro for adults with insufficiently controlled type 2 diabetes.
If a patient has type 2 diabetes and is taking insulin or a sulphonylurea, the doctor may consider dose adjustment to reduce low blood sugar risk. Singapore product information states that blood glucose self-monitoring is necessary when adjusting sulphonylurea or insulin doses with tirzepatide.
Why Lifestyle Care Still Matters
PCOS care is usually broader than medication alone.
SingHealth states that PCOS has no cure, but symptom control can be achieved with lifestyle and dietary modifications, and early diagnosis supports long-term health and prevention of metabolic and cardiovascular complications.
If Mounjaro is prescribed, it should still sit within a wider plan that may include nutrition, physical activity, sleep, stress management, menstrual health review, and cardiometabolic monitoring.
When a Doctor May Say Mounjaro Is Not Suitable
A doctor may decide Mounjaro is not suitable, or not suitable yet.
This may happen if the patient does not meet BMI or indication criteria, is planning pregnancy soon, has unresolved gastrointestinal symptoms, has unclear abdominal pain, has a relevant allergy, or needs further assessment of glucose, lipids, blood pressure, kidney function, or liver function.
Singapore product information lists hypersensitivity to tirzepatide or any excipient as a contraindication. It also states that safety and efficacy in children under 18 have not been established.
How Access Works in Singapore
Mounjaro should be accessed through a proper medical consultation and prescription pathway.
A doctor may assess suitability, explain expected monitoring, review side effects, decide whether lab tests are needed, and plan dose escalation. Singapore product information states that tirzepatide starts at 2.5 mg once weekly, then increases to 5 mg once weekly after 4 weeks, with further increases made after minimum intervals where clinically needed.
This gradual approach is especially relevant for people with PCOS who may already have gastrointestinal sensitivity, metformin use, fertility considerations, or metabolic risk factors.
Takeaway
You may be able to use Mounjaro in Singapore if you have PCOS, but PCOS or insulin resistance alone does not decide eligibility.
Doctors assess whether you meet approved criteria, whether PCOS is linked with metabolic risk, and whether treatment is safe alongside your current medicines, glucose status, fertility plans, and overall health. In Singapore, Mounjaro should only be used as a doctor-supervised prescription medicine.
FAQ
Can Mounjaro be used for PCOS in Singapore?
Mounjaro is not listed in Singapore product information as a standalone PCOS treatment. A doctor may consider it only if the patient meets relevant approved criteria, such as type 2 diabetes or weight-management criteria.
Does insulin resistance make me eligible for Mounjaro?
Not by itself. Doctors may assess insulin resistance through related metabolic markers such as HbA1c, fasting glucose, oral glucose tolerance testing, BMI, cholesterol, and blood pressure.
Is PCOS linked to type 2 diabetes risk?
Yes. SingHealth states that adolescents and adult women with PCOS are at increased risk for impaired glucose tolerance and type 2 diabetes.
Can I take Mounjaro with metformin?
Singapore product information states that when tirzepatide is added to existing metformin therapy, the current metformin dose can be continued. A doctor should still review whether the combination is appropriate for your situation.
What if I am trying to get pregnant?
Tell your doctor before starting treatment. The 2023 PCOS guideline advises effective contraception when pregnancy is possible for women using GLP-1 receptor agonists, because pregnancy safety data are lacking.
What should I prepare before a consultation?
Prepare your PCOS history, menstrual pattern, current medicines, latest HbA1c or glucose results, cholesterol results, blood pressure readings, weight and height, pregnancy plans, and previous weight-management attempts.
